Peripheral Arterial Disease Trial, Recruiting (NCT06066268)

Peripheral Arterial Disease Trial, Recruiting NCT06066268 Sponsor: IRCCS Policlinico S. Donato Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06066268 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People with severe limb-threatening poor blood flow (called critical limb ischemia, or CLI) who are scheduled for surgery to explore or bypass blood vessels behind the knee.
People with severe limb-threatening poor blood flow where the tissue damage is permanent and/or gangrene has developed in the lower limb, and who are scheduled for a major amputation of the lower limb.
People with a bulging (aneurysm) in the large blood vessel in the lower abdomen (but above the groin) who are scheduled for a minimally invasive procedure to repair it, and who do not have critical limb ischemia — this group includes both people with and without type 2 diabetes.

Who may not be able to join:

People who are pregnant.
People who have an inherited or genetic disease.
People who have been diagnosed with a malignant cancer (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Fabio Martelli, IRCCS Policlinico S. Donato

Phone: +39 0226437762

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06066268

Sponsor: IRCCS Policlinico S. Donato

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

Trial contact: +39 0226437762

More information: https://clinicaltrials.gov/study/NCT06066268

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People with severe limb-threatening poor blood flow (called critical limb ischemia, or CLI) who are scheduled for surgery to explore or bypass blood vessels behind the knee.
People with severe limb-threatening poor blood flow where the tissue damage is permanent and/or gangrene has developed in the lower limb, and who are scheduled for a major amputation of the lower limb.
People with a bulging (aneurysm) in the large blood vessel in the lower abdomen (but above the groin) who are scheduled for a minimally invasive procedure to repair it, and who do not have critical limb ischemia — this group includes both people with and without type 2 diabetes.

Who may not be able to join:

People who are pregnant.
People who have an inherited or genetic disease.
People who have been diagnosed with a malignant cancer (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

IRCCS Policlinico S. Donato

Registry

ClinicalTrials.gov

Start date

31 May 2016

Est. completion

31 May 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Identification of potentially pathogenic miRNAs in CLI and related target mRNAs.; Identification of disease biomarkers

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov